Allergies News and Research

Latest Allergies News and Research

Recent surge in group A streptococcal infections among children in UK

In an editorial published in the journal New Microbes and New Infections, scientists have highlighted the possible reasons behind a sudden rise in cases of group A streptococcal infections among children in the United Kingdom and other European countries.

18 Dec 2022

Exploring taste and smell dysfunction as strong predictors of SARS-CoV-2 infections

Researchers investigated whether coronavirus disease 2019 (COVID-19)-associated chemosensory alterations were predictive of serological responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among United States (US) residents.

16 Dec 2022

The UK's growing burden of long-COVID

Long COVID symptoms are more common in females and White identifying individuals between the ages of 35-49 years, as well as the disabled.

15 Dec 2022

Randomized trials demonstrate the safety of Ebola vaccine regimens in adults and children

Two randomized, placebo-controlled trials evaluating three Ebola vaccine administration strategies in adults and children found that all the regimens were safe in both age groups, according to results published today in the New England Journal of Medicine.

15 Dec 2022

Researchers seek to reduce Chikungunya virus-caused joint pain with new drug

Oregon Health & Science University researchers and partners are developing what could become the first-ever treatment against the debilitating joint pain that can last months or years after becoming infected with the emerging Chikungunya virus.

9 Dec 2022

Study shows how an inflammatory molecule causes life-threatening airway damage in asthma patients

An inflammatory molecule called LIGHT, appears to be the cause of life-threatening airway damage in patients with severe asthma.

9 Dec 2022

Multi-stage HIV vaccine regimen shows promising results in Phase 1 clinical trial

The George Washington University Vaccine Research Unit in partnership with Scripps Research, IAVI, Fred Hutchinson Cancer Center (FHCC) and the National Institutes of Health, National Institute of Allergy and Infectious Diseases Vaccine Research Center published the results of their Phase 1 Clinical Trial in Science.

8 Dec 2022

Research explores cell receptors for bat viruses to understand emergence of zoonotic diseases

New research shows that the closest bat virus relatives of the human Middle-East Respiratory Syndrome (MERS) coronavirus efficiently bind to bat ACE2 receptors as an entry point into these cells.

8 Dec 2022

Study reveals biological mechanism to explain why respiratory viruses spike in colder seasons

Researchers at Mass Eye and Ear and Northeastern University have discovered a previously unidentified immune response inside the nose that fights off viruses responsible for upper respiratory infections.

7 Dec 2022

Understanding why respiratory infections are more common in the winter

Researchers investigate the role of extracellular vesicles in the innate nasal mucosal response to several respiratory viruses.

6 Dec 2022

Machine learning analysis suggests that there are four sub-phenotypes of long COVID

Researchers identified PASC [post-acute sequelae of coronavirus disease 2019 (COVID-19)] sub-phenotypes depending on conditions diagnosed within 1 to 3 months of acute infection by SARS-CoV-2.

6 Dec 2022

Perinatal exposure to inorganic nanoparticles may make babies more vulnerable to food allergies

Nanotechnologies have revolutionized food technology with changes to food production, manufacture, and processing that are intended to make our food safer and healthier.

5 Dec 2022

Chemical residue from commercial dishwashers causes gut epithelial barrier damage

Residue from rinse agents is left behind on dishes after they are cleaned in professional-grade dishwashers.

1 Dec 2022

Study provides a framework to guide the development of variant-resistant SARS-CoV-2 vaccines

Latest research findings show that vaccine-elicited neutralizing antibodies against SARS-CoV-2 are mostly directed against one of the two main domains of the viral entry machinery.

30 Nov 2022

Severe undernutrition increases risk of unfavorable outcomes for individuals undergoing TB treatment

In 2021, an estimated 10.6 million individuals developed tuberculosis (TB) and 1.6 million died, making it the second most lethal infection in the world after SARS-CoV-2.

30 Nov 2022

Researchers receive $3 million-plus NIH grant to develop treatment for drug-resistant fungus

With a new $3 million-plus grant from the National Institutes of Health (NIH), Case Western Reserve University researchers are examining the next level of treatment for Candida auris (C.auris), a multidrug-resistant yeast that causes serious infection and, in some cases, death.

30 Nov 2022

£12 million awarded to innovative UK regulators to help drive technology and personalized medicine

Science Minister George Freeman has today (30 November) awarded up to £12 million to UK regulators to help drive forward innovation, remove red tape and establish the UK as world leader in technologies of the future - from AI to help treat rare diseases, to drones monitoring safety on construction sites.

30 Nov 2022

Effects of early postnatal exposure to antibiotics on incidence of early-onset sepsis

Researchers investigated the effects of early postnatal antibiotic exposure among infants in the participating networks of high-income countries.

30 Nov 2022

Pregnant people can safely take Paxlovid to reduce the possibility of severe COVID-19, study shows

Findings from a Johns Hopkins Medicine research study published today in JAMA Network Open provide strong evidence that people who are pregnant and have been infected with SARS-CoV-2 (the virus that causes COVID-19) can safely take the antiviral drug Paxlovid to reduce the possibility of severe disease.

29 Nov 2022

Acute COVID-19 infection disrupts a healthy balance between good and bad gut microbes

In an intensive look at the effects of the virus causing COVID-19 on patients' microbiome – the collection of microorganisms that live in and on the human body – Rutgers scientists found that acute infection disrupts a healthy balance between good and bad microbes in the gut, especially with antibiotic treatment.

28 Nov 2022

Allergies News and Research

Latest Allergies News and Research

Recent surge in group A streptococcal infections among children in UK

Exploring taste and smell dysfunction as strong predictors of SARS-CoV-2 infections

The UK's growing burden of long-COVID

Randomized trials demonstrate the safety of Ebola vaccine regimens in adults and children

Researchers seek to reduce Chikungunya virus-caused joint pain with new drug

Study shows how an inflammatory molecule causes life-threatening airway damage in asthma patients

Multi-stage HIV vaccine regimen shows promising results in Phase 1 clinical trial

Research explores cell receptors for bat viruses to understand emergence of zoonotic diseases

Study reveals biological mechanism to explain why respiratory viruses spike in colder seasons

Understanding why respiratory infections are more common in the winter

Machine learning analysis suggests that there are four sub-phenotypes of long COVID

Perinatal exposure to inorganic nanoparticles may make babies more vulnerable to food allergies

Chemical residue from commercial dishwashers causes gut epithelial barrier damage

Study provides a framework to guide the development of variant-resistant SARS-CoV-2 vaccines

Severe undernutrition increases risk of unfavorable outcomes for individuals undergoing TB treatment

Researchers receive $3 million-plus NIH grant to develop treatment for drug-resistant fungus

£12 million awarded to innovative UK regulators to help drive technology and personalized medicine

Effects of early postnatal exposure to antibiotics on incidence of early-onset sepsis

Pregnant people can safely take Paxlovid to reduce the possibility of severe COVID-19, study shows

Acute COVID-19 infection disrupts a healthy balance between good and bad gut microbes

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Allergies News and Research

Latest Allergies News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in